Vertex Chambers has advised a leading pharmaceutical company on the legal permissibility of investing provident and gratuity fund assets in corporate instruments, including zero coupon bonds and preference shares. The engagement involved analyzing statutory investment restrictions under trust and company law and structuring compliant investment pathways while addressing fiduciary and regulatory constraints.